Twelve laboratory beagles underwent a routine left thoracotomy to insert permanent instrumentation. Every second dog was given 10/lg/kg of medetomidine, an !X2-agonist sedative. The rest of the animals were treated with 20/lg/kg of buprenorphine, an opioid agonist-antagonist, which is regularly used to treat postoperative pain in laboratory animals. The drugs were given at the end of operation (0) and 4, 8, 20, and 24 h postoperatively. Blood samples for catecholamines (adrenaline and noradrenaline) and blood gases [pC0 2 and p02) and pH were drawn immediately before any drug administration, and 30 min later. At the same time points, the pain level was subjectively evaluated using a pain score, and heart rate and rectal temperature were measured.
Adequate postoperative pain alleviation in animals is generally considered essential. A rule of thumb has been: if a procedure is painful in human, it most probably is painful also in animals. However, it is difficult to determine the adequacy of pain treatment accurately, as animals sometimes seem to recover more rapidly than humans from a comparable operation. In practice, as we are still lacking a well validated score for assessment of the intensity of postoperative pain in animals, postoperative pain treatment is based Correspondence co: Dr Outi Vainio Accepted 30 November 1993 on subjective evaluation and may, therefore, lead to use of an inappropriate drug regime.
Flecknell and Liles (1991al used food and water intake, and spontaneous locomotor activity as indices for postoperative pain in laboratory rats which underwent routine surgical procedures. Inhibition of reduction in food and water uptake, and prevention of depression in locomotor activity by an opioid, nalbuphine, were considered as signs of postoperative pain and distress alleviation. In their further studies, Flecknell et al. (1991bJ used effectiveness of pulmonary ventilation (blood gas measurement) to evaluate the analgesic effect of intercostal bupivacaine and parenteral nalbuphine, which were used to alleviate postoperative pain in dogs following thoracotomy. Increased sympathetic nervous system activity induced by pain, fear, tissue damage, and haemorrhage may result in an elevation in circulating catecholamines. Both accidental injuries (Davies et a1. 1984) and surgical interventions (Benson et 01. 1991) increased plasma noradrenaline and adrenaline levels in man [Davies et a1. 1984) and animals (Benson et a1. 1991) . Benson (1991) found that onychectomy in cats increased plasma catecholamine levels, which were decreased postoperatively by morphine or xylazine (but not by salicylate). This decline in noradrenaline and adrenaline concentrations was considered as a sign of an analgesic effect of the drugs used. Furthermore, it was stated that postoperative catecholamine responses could be used to assess objectively the presence of pain and its relief by analgesic drugs (Benson et a1. 1991) . Additionally, plasma levels of {3endorphins have been found to correlate with perioperative pain: opiate agonists suppressed the level of ,6-endorphins, and this probably occurred because of diminished pain perception (Hargreaves et a1. 1986). Medetomidine is a relatively new sedative drug, which is used for sedation and analgesia in dogs and cats (Vainio et a1. 1986 ). Medetomidine has its effect mainly via activation of both central and peripheral a2-adrenoreceptors (Scheinin et a1. 1989) . Central activation of a2-adrenoreceptors results in sympathetic depression with clinical signs such as reduced stage of vigilance (sedation), increased pain threshold (analgesia), and haemodynamic changes, e.g. initial hypertension and bradycardia (Scheinin et a1. 1989) . When used conventionally, medetomidine is given to animals before any painful procedure has been performed. However, as the sedative and analgesic effect of medetomidine is dose dependent (Vainio et a1. 1989) , doses which are considerably less than those used clinically Vainio & Ojala should not be without effect. Medetomidine is known to decrease the turnover of noradrenaline in rat brain (Scheinin et a1. 1989 ) and noradrenaline plasma level in mini pigs (Vainio et a1. 1992 ). Medetomidine's ability to decrease plasma noradrenaline concentration may hint that medetomidine could also be effective to alleviate postoperative pain. As clinical sedation is not usually desired in postoperative treatment, the effects of nonsedative doses of medetomidine, would be of interest.
Thoracotomy is a major surgical operation which may cause changes in pulmonary function because of postoperative pain both in man (Entwistle et a1. 1991 ) and animals fFlecknell et a1. 1991b). To control this postthoracotomy pain, both systemic opioids (nalbuphine) and/ or intercostal nerve block with a long standing local anaesthetic fbupivacaine) have been used successfully in dogs (Flecknell et a1. 1991b) . In our facilities, laboratory beagles undergoing a routine thoracotomy to insert a permanent catheter into the aorta, are routinely given analgesics including a local anaesthetic, bupivacaine, and a parenterally injected long lasting opioid, buprenorphine. Buprenorphine is a frequently used analgesic in laboratory animals and, as a partial wagonist, buprenorphine is unlikely to depress ventilation although this may occur in rare cases (Hall & Clarke 1991) .
The purpose of the present work was: to study, if 'lower than normal' doses of medetomidine, e.g. non-sedative doses would alleviate post-thoracotomy pain, and to compare the possible postoperative analgesic effect of medetomidine to that of buprenorphine in thoracotomized dogs.
Material and methods
All experimentation was approved by the Animal Care Committee of Orion Corporation. The animals involved were bred for experimental purposes by a commercial breeder.
Twelve healthy laboratory beagles r 6 males and 6 females) undergoing a routine left thoracotomy were included. The dogs were from 8 months to 2.5 years of age and weighed from 9.3 kg to 11.6 kg. The dogs were premedicated intramuscularly with 40 ltg/kg of medetomidine [Domitor, Orion Corporation) and, 10 min later, anaesthetized with a slow intravenous propofol (Diprivan, ICI) bolus injection of 4 mg/kg. Anaesthesia was maintained with an adequate concentration of halothane [1-3%, vaporizer setting) in a 2/3: 1/3 mixture of oxygen and nitrous oxide. Intermittent positive pressure ventilation (Fluidor 2000, Medishield) , with a tidal volume of 200 ml, and a ventilation rate of 20 breaths/min was commenced. Intravenous saline (10ml/kg/h) was started after connection to halothane. The left flank was surgically prepared and the chest was opened between the 5th and 6th rib. A permanent catheter (Silastic Medical Grade Tubing cat. no. 602-285, Dow Corning Corporation) was inserted into the descending aorta for measurement of arterial blood pressure and withdrawal of arterial blood samples. The catheter was tunnelled subcutaneously and capped with a plastic cap with a rubber membrane lB. Braun Melsung AG). This cap was fixed subcutaneously on the dorsal region of the neck. Before closing the chest, 10ml of 0.25% bupivacaine (Marcain, Astra) was infiltrated into the intercostal muscles next to the incision. Finally, pneumothorax was reduced using a chest drain. The dogs were daily treated with 1g of intravenous ceftriaxone (Rocephalin, Roche) for 10 days, starting the day of surgery.
After laryngeal reflexes had returned, the dogs were extubated. Animals received either medetomidine (10ltg/kg) or buprenorphine (20ltg/kg) immediately after extubation, and 4, 8, 20, and 24 h post extubation. Both drugs were injected intramuscularly. Two blood samples were taken, one for arterial p02, pC0 2 , and pH measurements and a second sample for noradrenaline and adrenaline measurements immediately before drug administration and 30 min later. The blood samples were drawn anaerobically lfor 371 blood gases), capped, and placed on ice. The samples for p02, peo 2 , and pH were analysed within 15min by an automated blood gas analyser IlL BGE, Instrumentation Laboratory). The catecholamine samples were centrifuged in a refrigerated centrifuge, and the plasma was drawn off and stored at -80°C. The analysis of noradrenaline and adrenaline is described in detail elsewhere (Scheinin et 01. I987). For both of the catecholamines analysed, the detection limit was 0.02 nmol/I. At the above mentioned time points, immediately before drawing blood samples, heart rate was taken using a stethoscope, rectal temperature measured, and the degree of pain was subjectively evaluated by the same trained person. The pain score was as follows: 4-severe pain, lies, vocalizes, no eye contract; 3-moderate pain, lies, silent, eye contact; 2-slight pain, stands, walks carefully; I-otherwise normal, responds to touch; O-painless, no special pain behaviour.
Analysis of variance (ANOVA)for unbalanced repeated measures was used for statistical analysis. The factors used in ANOVA were drug and time. If the ANOVA indicated a significant interaction between time and group, the analysis was continued by calculating differences between the baseline time and at each successive time point after the drugs were administered and by comparing these between groups. The computations were conducted by using the MIXED-procedure of SAS Statistical Software (SASInstitute Inc., Cary, North Carolina, USA). The data are presented as the arithmetical mean ± standard deviation [SD). A P value less than 0.05 was considered statistically significant.
Results
In the buprenorphine group, adrenaline concentration increased significantly from 0.3 ± 0.3 nmol/l to 6.9 ± 6.2 nmol/l within the first 4 h after operation, as shown in Fig. 1 . The latter was the highest adrenaline concentration measured, and an additional buprenorphine injection at 4 h * Adrenaline concentration (nmol/l) 14 postoperatively, proved to be without immediate effect on adrenaline concentration. In the medetomidine group, no evident changes of adrenaline concentration were seen within the same time interval, or during the whole follow up period. Postoperative noradrenaline concentration significantly increased in the buprenorphine group. The highest noradrenaline concentration, 3.3 ± 1.9 nmol/l, was measured at the end of the 24.5 h follow up period, for more details, see Fig. 2 trend of increasing concentration of noradrenaline was not seen in the medetomidine group.
The subjectively evaluated postoperative pain level of the dogs was interpreted to have a decreasing trend as the pain score lowered from 2.3 ± 0.5 and 1.8 ± 0.8 to 0.8 ± 0.4 and 0.2 ± 0.5 in buprenorphine and medetomidine groups, respectively, during the 24.5 h follow up period (see Table 1 ).
Arterial p02 decreased after the first postoperative injections of buprenorphine (from 93 ± 29 mmHg to 54 ± 14 mmHg) and medetomidine (from 109 ± 29 mmHg to 79 ± 11 mmHg) (see Fig. 3 ) but these reductions were not significant (P=0.073).
Noradrenaline concentration (nmol/I) 6 Partial pressure of O2(mmHg) Subsequent injections of each drug had no effect on p02' Arterial pC0 2 declined from the end-ofoperation level (55± 19mmHg and 56 ± 13mmHg in buprenorphine and medetomidine groups, respectively) to 40 ± 3 mmHg after buprenorphine and to 38 ± 4 mmHg after medetomidine, during the first 4 h of postoperative period, as shown in Fig. 4 but these reductions were not significant (P=0.72991. No changes in arterial pC0 2 occurred thereafter with either drug used.
After termination of the operation, pH increased during the first 4 h from 7.169±0.144 to 7.332±0.016 in the buprenorphine treated group, and from 7.191±0.105 to 7.367±0.023 in the medetomidine group. The change in pH was comparable in both treatment groups and lacked statistical significance.
Heart rate increased steadily from 57 ± 15 beats/min to 88 ± 19 beats/min during the follow up period in the buprenorphine group. In the medetomidine group, the before-drug values showed an increasing trend, but heart rate declined following each administration of medetomidine. The smallest decrease (14%) occurred after the first medetomidine injection, and the largest decrease (42%) after the last medetomidine injection (see Fig. 5 ). The difference between the groups was statistically significant (P<0.05).
Initially, rectal temperature had a slight decreasing trend from 36.0± 1.2°C to 35.6± 1.7°C and from 36.3±0.6°C to 35.3 ± 1.7°C in the buprenorphine and medetomidine groups, respectively, the lowest body temperature was measured at 4 h after the operation had finished. Rectal temperature increased to preoperative levels (39.0± 0.1°C in the buprenorphine group and 38.4 ± O.4°C in the medetomidine group) at 8 h after operation and remained stable for the rest of the follow up period.
Discussion
No untreated control (placebo) was used in this study due to the fact that local anaesthetic and buprenorphine is an acceptable standard regimen to use as a positive control and, thus, the scientific objective could be obtained without denying analgesia to one group of animals.
Every kind of pain and distress, including surgical interventions, evidently increase the concentration of circulating catecholamines in animals and man (Davies et al. 1984 , Benson et al. 1991 . Therefore, plasma catecholamine levels may be an objective indicator of the presence of pain and distress. However, the reduction in plasma catecholamines seen after administration of 0!2-agonistsmay be due to actions other than an analgesic effect. Due to their sympatholytic effect, 0!2-agonistsare known to decrease the circulating catecholamine levels also in normal, pain-free animals. It is possible, especially in the case of sedative 0!2-agonists,that reduced catecholamine concentrations do not correlate with true pain alleviation, but that the sedative effect prevents the animals from responding to pain. In the present study, reduced catecholamines were considered to indicate less severe postoperative stress rather than as evidence of true analgesia.
The highest adrenaline concentration (6.9 ± 6.2 nmol/l) was measured at 4 h after thoracotomy in the dogs which received buprenorphine to alleviate postoperative pain. This adrenaline concentration was significantly higher than in those dogs which were given medetomidine (l.0± l.Onmol/l) at the same time point (Fig. 1) . Consequently, based on the lower adrenaline level in the medetomidine group, it was concluded that these dogs had less postoperative distress, including pain, than the animals in the buprenorphine group. Also noradrenaline concentration in the buprenorphine-treated dogs stayed above that in the medetomidine-injected animals. This was particularly noticeable from 8 h onwards (Fig. 2) . The increase at this time may be because the effect of bupivacaine, the local anaesthetic, persisted for approximately 8 h but thereafter was ineffective, and buprenorphine alone was less effective than medetomidine in controlling postoperative pain. If buprenorphine had been given at some time earlier than extubation, its analgesic activity might have been more marked. The subjective evaluation of the postoperative pain level (Table I) , even though not considered especially reliable in this clinical study, supported the results that medetomidine was more effective in alleviating postoperative pain and distress than buprenorphine, in thoracotomized dogs.
Vainio & Ojala
The finding that an O!ragonist possessed equal (or better) postoperative analgesic than an opioid, was not totally unexpected. Comparable results were observed in a study by Benson et a1. (1991) , where morphine and xylazine, another 0!2-agonist, were used postoperatively in onychectomized cats. Both drugs are recognized as potent analgesics which significantly decrease plasma catecholamines. In the present work, even though buprenorphine (20/lg/kg) was used at the recommended dose (Flecknell 1987) , the drug was administered more frequently than suggested (in 4 h intervals instead of 8 and 12 h (Short 1987)). As an opioid agonist-antagonist, use of too high a dose of buprenorphine might have antagonized, at least in theory, some of the analgesic effect of the drug. However, Cowan et 01. (1977) showed in rats that a lO-fold increase in dose rate was needed to move beyond the plateau of maximum effect and to show a reduction in analgesic effect.
In some dogs, p02 was above the normal level at the end of the operation, due to the use of oxygen as a carrier gas during anaesthesia (Fig.3) . p02 decreased after the first injection of the drugs (time 0). Lowest p02 values, 54.2± 13.5 mmHg and 78.8 ± 11.0 mmHg, were recorded at 30 min postoperatively for buprenorphine and medetomidine groups, respectively. This initial decline of p02 was greater in the dogs which received buprenorphine (42%) than in the dogs given medetomidine (28%). This would indicate that immediately after operation, buprenorphine depressed respiratory function more than medetomidine. Thompson and Johnson (1991) also reported that postoperative p02 was significantly lower in thoracotomized dogs which were treated with morphine (0.5 mg/kg) instead of intercostal bupivacaine.
pC02 increased in both groups at the end of the operation and returned to normal level within 4 h (Fig.4 ). pH was low (between 7.169±0.144 and 7.l9l±0.105) in both groups at the completion of surgery, indicating the presence of an intraoperative respiratory acidosis. However, this situation was corrected during the follow up period.
Repeated medetomidine injections decreased heart rate after each administration (Fig. 5) . The higher the pre-drug heart rate was, the greater the decrease seen. Bradycardia is a side-effect seen when medetomidine (and other cx2-agonists) are used in dogs. Although the bradycardic effect 6f medetomidine does not show a strong correlation with dose rate in the range of doses used clinically (Vainio &. Palmu 1989) , it is possible that the depressant effect on heart rate would be minimized if lower doses of medetomidine were used.
In conclusion, based on significantly lower catecholamine concentrations, medetomidine (10 ltg/kg) proved to have a better postoperative analgesic effect than buprenorphine (20 ltg/kg) in thoracotomized dogs. This result was supported by subjective evaluation of the severity of pain, even though subjective evaluation is not considered very reliable in the present kind of open studies. In selected gases, analgesia accompanied by sedation might be beneficial and medetomidine (and other cx2-agonists) would fulfil these needs. In general, cx2-agonists may possess some potential in postoperative pain alleviation and this requires further studies. 
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